Connect with us

Business

Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent – ABC News

Pfizer will ask regulators for the pill to be made available for global use as soon as possible after clinical trials suggested…

Published

on

Article feature image

Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:

  • Pfizer says preliminary…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending